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Abstract
Background: Two pertussis toxin sensitive Gi proteins, Gi2 and Gi3, are expressed in cardiomyocytes and upregulated in
heart failure. It has been proposed that the highly homologous Gi isoforms are functionally distinct. To test for isoform-
specific functions of Gi proteins, we examined their role in the regulation of cardiac L-type voltage-dependent calcium
channels (L-VDCC).
Methods: Ventricular tissues and isolated myocytes were obtained from mice with targeted deletion of either Gai2 (Gai2
2/2)
or Gai3 (Gai3
2/2). mRNA levels of Gai/o isoforms and L-VDCC subunits were quantified by real-time PCR. Gai and Cava1
protein levels as well as protein kinase B/Akt and extracellular signal-regulated kinases 1/2 (ERK1/2) phosphorylation levels
were assessed by immunoblot analysis. L-VDCC function was assessed by whole-cell and single-channel current recordings.
Results: In cardiac tissue from Gai2
2/2 mice, Gai3 mRNA and protein expression was upregulated to 187621% and
567659%, respectively. In Gai3
2/2 mouse hearts, Gai2 mRNA (12765%) and protein (131610%) levels were slightly
enhanced. Interestingly, L-VDCC current density in cardiomyocytes from Gai2
2/2 mice was lowered (27.960.6 pA/pF,
n=11, p,0.05) compared to wild-type cells (210.760.5 pA/pF, n=22), whereas it was increased in myocytes from Gai3
2/2
mice (214.360.8 pA/pF, n=14, p,0.05). Steady-state inactivation was shifted to negative potentials, and recovery kinetics
slowed in the absence of Gai2 (but not of Gai3) and following treatment with pertussis toxin in Gai3
2/2. The pore forming
Cava1 protein level was unchanged in all mouse models analyzed, similar to mRNA levels of Cava1 and Cavb2 subunits.
Interestingly, at the cellular signalling level, phosphorylation assays revealed abolished carbachol-triggered activation of
ERK1/2 in mice lacking Gai2.
Conclusion: Our data provide novel evidence for an isoform-specific modulation of L-VDCC by Gai proteins. In particular,
loss of Gai2 is reflected by alterations in channel kinetics and likely involves an impairment of the ERK1/2 signalling pathway.
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Introduction
G protein-mediated signalling plays a central role in regulation of
cardiomyocyte function. Heterotrimeric G proteins consist of three
subunits, Ga,G b,a n dG c. Agonist-occupied receptors induce
dissociation of GDP from and binding of GTP to the G protein a
subunit, resulting in G protein activation. Activated Ga and Gbc
subunits coupleto a plethoraofeffectors,including enzymes and ion
channels, and hence are involved in many regulatory processes
[1,2]. The role of stimulatory Gs and inhibitory Gi proteins in
cardiac signalling pathways is well studied [3,4]. Alterations of Gai
protein expression levels are found in heart disease [5], and heart
failure in humans leads to upregulation of Gai2 and Gai3 [6,7,8,9].
Whether the upregulation of Gai2 and Gai3 in cardiomyocytes is
causative, adaptive, or maladaptive still remains unclear.
Cardiac calcium channels are key components in complex
signal transduction pathways and play an essential role in cardiac
excitability and in coupling excitation to contraction [10]. One
major pathway regulating calcium channels is mediated via G
protein-mediated signalling. In the heart, the main sarcolemmal
calcium channel is the voltage-dependent L-type calcium channel
(L-VDCC). This channel is composed of three different subunits.
The a1 subunit represents the pore forming subunit which
contains the voltage sensor and the binding sites for calcium
channel modulators [11]. It associates with two auxiliary subunits,
b, and a2d [12]. The functional properties of the pore forming
subunit are differentially modified due to interaction with various
b subunit isoforms [13,14,15,16]. Furthermore, receptor activated
Gas protein stimulates L-VDCCs via adenylyl cyclase-mediated
increases in cAMP levels and protein kinase A (PKA) activity [3].
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cascades [17]. Thus, G protein signalling pathways are crucial in
determining and balancing cardiomyocyte function in vivo.
In a previous study we addressed the role of Gai2 in b2-
adrenergic receptor-mediated signalling. Gene deletion of Gai2 in
mice reduced single L-VDCC activity in b2-adrenergic receptor-
transgenic mice [18], whereas pertussis toxin (PTX) treatment
reversed this effect. We speculated that this unexpected effect of
PTX may have been caused by inhibiting an upregulated Gai3.
Recently, Zuberi et al. [19] showed that Gai2 knockout leads to
increased L-VDCC mRNA expression and a propensity towards
ventricular arrhythmia. Muscarinic receptor-mediated inhibition
of L-VDCC activity has been reported to depend on Gai2 but not
Gai3 [20]. Though strongly suggested by these data, subtype-
specific effects on cardiac L-VDCC by the highly homologous
Gai2 and Gai3 isoforms remain unclear so far. Therefore, the
present work was undertaken to elucidate whether the effects of
these Gai proteins are redundant or distinct. Using cardiomyo-
cytes from mice lacking Gai2 or Gai3 and wild-type (WT) control
animals, we determined structural and functional changes.
Further, we examined specific signalling pathways implicated in
cardiac L-VDCC modulation by Gai protein. In this work, we
provide evidence that the L-VDCC activity and kinetics are
regulated in a non-redundant manner and we support this idea by
demonstrating subtype-specific activation of the extracellular
signal-regulated kinases 1/2 (ERK1/2) signalling cascade.
Results
Gai2 deficiency decreases, while Gai3 deficiency increases
L-VDCC current density
To assess consequences of selective deletion of Gai2 or Gai3 genes,
we measured whole-cell L-VDCC currents in cardiomyocytes from
WT, Gai2
2/2,a n dG ai3
2/2 mice. Currents recorded at different test
potentials are shown as representative original recordings and
current-voltage diagrams of summarized data in Fig. 1A and B,
respectively. In cardiomyocytes of Gai2
2/2 mice, the calcium cur-
rent density at 0 mV was slightly but significantly reduced
(27.960.6 pA/pF, n=11, p,0.05) compared to WT
(210.760.5 pA/pF, n=22). In contrast, current density in cardio-
myocytes from Gai3
2/2 mice was increased (to 214.360.8 pA/pF,
n=14, p,0.05 vs. WT). Of note, the peak current in Gai2
2/2
cardiomyocytes is shifted towards higher voltages. Comparison of
time-dependent inactivation by fitting revealed no alterations of fast
and slow time constants in all genotypes (e.g. at 0 mV, tfast:
WT=18.461.0 ms, Gai2
2/2=26.964.0 ms and Gai3
2/2
=15.162.1 ms; tslow:W T=9 5 . 3 64.2 ms, Gai2
2/2=97.5617 ms
and Gai3
2/2=94.969.9 ms; n=10–13). To test whether changes in
Figure 1. Cardiac whole-cell L-type calcium currents. Representative original current traces obtained at different test potentials (A) and IV-
curves (B) reveal an increase of calcium current in ventricular myocytes from mice lacking Gai3 and a decrease in mice lacking Gai2 as compared to WT
mice. (C) Steady-state inactivation of Gai2
2/2 (n=11) is shifted to more negative voltages as compared to Gai3
2/2 (n=13, p,0.05) and WT (n=18,
p,0.05). (D) A slowing of the recovery time constant t is found in cardiomyocytes from Gai2
2/2 mice (287621 ms, n=9) as compared to Gai3
2/2
cells (n=9) and WT (n=16).
doi:10.1371/journal.pone.0024979.g001
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examined kinetic and steady state properties of activation and
inactivation.
L-VDCC kinetics are altered by Gai2 deletion, but not by
Gai3 deletion
The steady-state inactivation properties (Fig. 1C) in Gai2
2/2
cardiomyocytes were altered compared to WT cells as reflected by
a significant leftward shift of V0.5 (Gai2
2/2: 223.461.0 mV,
n=11, WT: 219.260.7 mV, n=18) and an increased slope
factor (Table 1). In addition, recovery from inactivation was
slowed in cardiomyocytes from mice lacking Gai2 (t: 287621 ms,
n=9, p,0.05) in comparison to WT animals (t: 215614 ms,
n=16; Fig. 1D). In contrast, whole-cell currents in cells form
Gai3
2/2 mice were indistinguishable from WT regarding both
steady state inactivation (V0.5: 218.260.9 mV, n=13, Table 1)
and recovery from inactivation (t: 203624 ms, n=9). Thus,
currents from Gai2
2/2 mice show altered kinetic properties and
this might explain the decreased current density described above
(Fig. 1). Despite increased current density no alteration of current
kinetics in Gai3
2/2 myocytes was visible. Thus we analyzed single-
channel activity to elucidate the opposing effects seen on whole-
cell currents in Gai2
2/2 and Gai3
2/2 cardiomyocytes.
No major changes in gating properties of single L-VDCC
in Gai3
2/2 cardiomyocytes
Single-channel current recordings in Gai3
2/2 cardiomyocytes
revealed a trend towards increased peak ensemble average
currents (Fig. 2B) and higher open probability (Fig. 2C) when
compared to WT cardiomyocytes (Table 2). These effects are
based on a significant reduction of the mean closed time
(3.860.5 ms vs. 6.660.9 ms, n=6–7, p,0.05; Fig. 2D). Together
with a significantly decreased slow time constant of the closed state
and by trend a reduced first latency (Table 2) our single-channel
data suggest that in Gai3
2/2 exit from deeper closed states of L-
VDCC is facilitated. Given that single-channel activity in Gai2
2/2
mice was decreased by trend [18] our findings presented here
suggest that Gai2
2/2 or Gai3
2/2 knockout leads to distinct
changes of cardiac L-VDCC properties. Yet, these only slight
functional changes alone do not elucidate the more remarkable
augmentation of calcium current density in Gai3
2/2. Since the
remaining Gai isoform might have compensated for effects of Gai3
deficiency we next checked the expression levels of Gai2 in Gai3
knockouts and vice versa.
Enhanced expression levels of remaining Gai isoform
If the generally accepted assumption holds true that Gai2 and
Gai3 proteins are functionally redundant in the heart, we could
expect a compensatory upregulation of the remaining Gai subunit
after knockout of the other. We first determined mRNA expression
levels for Gai1,G ai2,G ai3, and Gao in samples from WT,
Gai2
2/2, and Gai3
2/2 mice using real-time PCR. In ventricular
tissue from WT mice, transcripts for all Gai protein isoforms and
Gao were found in different amounts (Fig. 3A). While Gai2 and
Gai3 are known to be expressed in cardiomyocytes - with Gai3
mRNA being clearly less abundant -, Gai1 and Gao are likely
transcribed in non-cardiomyocyte ventricular cells [21]. Deletion
of Gai2 enhanced the mRNA level of Gai3 (to 187621%, n=3,
p,0.05 vs. WT), as expected [6,22]. In cardiac tissue of Gai3
2/2
mice Gai2 mRNA levels were upregulated to only 12765% (n=4,
p,0.05 vs. WT). No significant changes in Gao or Gai1 mRNA
expression levels were detected, which is in line with the
assumption, that these G proteins are not expressed in cardiomy-
ocytes (see above and Fig. 3B).
Next, protein expression of Gai isoforms was analyzed in cell
membrane preparations from WT, Gai2
2/2,a n dG ai3
2/2
ventricles by probing with Gacommon antibodies subsequent to
high resolution urea/SDS-PAGE-separation of proteins. WT
mice expressed both Gai2 and Gai3 subunits with the protein
level of Gai2 being much higher than that of Gai3 (Fig. 3C), in
line with previous studies (e.g. [22]). As expected, in hearts from
Gai2
2/2 mice Gai3 was found and Gai2 was absent while in
hearts from Gai3
2/2 mice, only Gai2 was detectable (Fig. 3C).
The specificity of the detected Gai2 and Gai3 protein bands in
Gai2
2/2,G ai3
2/2 and WT cardiac tissue was confirmed by
analyzing the expression of Gai isoforms by PTX-mediated
[
32P]ADP ribosylation [23] (data not shown). These experiments
prove that gene deletion indeed led to loss of the Ga subunit.
Statistical analysis of relative expression levels obtained from
immunoblots (Fig. 3D) show that Gai2 protein is significantly
upregulated in ventricles obtained from Gai3
2/2 mice (to
131610%, n=8, p,0.05 vs. WT). However, Gai3 protein is
much more markedly upregulated upon Gai2 deficiency (to
567659%, n=8, p,0.05 vs. WT). Taken together, knockout
models examined in this study feature a protein upregulation of
the respective other Gai isoform. These data, together with
quantitative mRNA data reported above, suggest that increased
levels of Gai2 or Gai3 may partially compensate for the loss of the
deleted other Gai isoform. Hence, any effect seen so far could be
caused by the loss of one Gai protein and/or compensatory
signalling exerted by the other. Unfortunately, double-deficient
(Gai2
2/2/Gai3
2/2) mice are not viable [22] and hence cannot
be used to directly address this question. However, all Gi proteins
can acutely be inactivated by PTX treatment.
Acute Gi inactivation induces L-VDCC kinetic alterations
in Gai3
2/2 cardiomyocytes
We performed experiments with PTX for acute inactivation of
Gi/o proteins in cardiomyocytes of WT and Gai-deficient mice.
Freshly isolated cardiomyocytes were incubated at 37uC with or
without PTX for 3 hours and afterwards maintained and
examined at room temperature. It has been shown that this
protocol completely ablates Gi-mediated signalling, e.g. when
triggered by adenosine receptors [24]. Of note, the 3 hours
incubation phase – even in the absence of PTX – reduced current
density in Gai3-deficient cells (Fig. 4A). Notably, similar to WT
cells, PTX treatment in Gai3
2/2 myocytes induced a shift of V0.5
for steady state inactivation to more negative potentials (to
222.761.1 mV, n=11; Fig. 4B). Likewise, the recovery from
inactivation in Gai3
2/2 cardiomyocytes was slowed by PTX
treatment (to t: 350627 ms, n=8 p,0.05 vs. WT; Fig. 4C). In
contrast, the calcium current phenotype in Gai2
2/2 cells was
preserved with time and resistant to treatment with PTX. To
Table 1. Steady-state inactivation parameters.
Parameter WT Gai2
2/2 Gai3
2/2
V0.5 (mV) 219.160.7 223.461.0*
{ 218.260.9
Slope factor (mV) 5.260.2 8.760.6*
{ 5.460.2
In Gai2
2/2 cardiomyocytes V0.5 of the steady-state inactivation is significantly
shifted to more negative potentials. In addition, Boltzmann fits revealed a
significant flattening of the curves as indicated by increased slope factors.
*p,0.05 vs. WT,
{p,0.05 vs. Gai3
2/2.
doi:10.1371/journal.pone.0024979.t001
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2/2
but not from Gai2
2/2 mice. In Gai3
2/2, acute PTX treatment –
and thus inactivation of Gai2
2/2 – mimics the kinetic changes
induced by chronic gene deletion of Gai2
2/2. In contrast, the
effect of Gai3 gene deletion appears to be transient and does not
interfere with channel kinetics. Because some of the calcium
current changes reported here may be caused by (long-term)
structural alterations rather than (acute) functional modulation of
calcium channels, we next examined channel composition.
No significant structural modification of L-VDCC
To obtain insight into the effects of specific and constitutive Gai-
deficiency on L-VDCC structure and expression, we determined
RNA expression levels of the pore forming Cava1 subunit and the
predominant murine cardiac Cavb subunit, Cavb2 [14,16,25],
which is involved in calcium channel trafficking and gating
[26,27,28]. The Cavb2 subunit mRNA expression in ventricles
from Gai2
2/2 and Gai3
2/2 animals is not altered compared to
WT expression profile (Fig. 5B). In Gai2
2/2 and Gai3
2/2
ventricles, the pore forming Cava1 subunit mRNA (Fig. 5B) and
membrane protein (Fig. 5C and D) expression levels exhibit only
slight and insignificant changes. Thus, these data do not suffice to
explain the Gai isoform-specific regulation of the current density.
Therefore, we next switched to the posttranslational level and
addressed signalling pathways that are involved in Gi protein-
mediated action.
Figure 2. Single-channel properties of L-type calcium channels. (A) Exemplary traces of barium currents show increased single-channel
activity in ventricular myocytes of Gai3
2/2 animals vs. WT mice. (B) The peak ensemble average current is 261613 fA in Gai3
2/2 (n=6) and
24469 fA in WT mice (n=7). (C) The open probability within active sweeps is slightly enhanced in Gai3
2/2 (5.461.0% vs. 4.060.9% WT) whereas (D)
the mean closed time is significantly reduced (Gai3
2/2 3.860.5 ms vs. 6.660.9 ms WT). Unitary amplitude was not different with 20.8360.02 pA (WT)
and 20.7960.03 pA (Gai3
2/2). *p,0.05 vs. WT. Box-and-whisker plots indicate minimum and maximum values as well as 25
th,5 0
th and 75
th
percentiles.
doi:10.1371/journal.pone.0024979.g002
Gai Isoform-Specific Regulation of Ca
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Cardiac Gai is known to activate the PI3-kinase Akt/PKB
pathway [29], and Akt-mediated b-subunit phosphorylation
prevents Cava1 degradation [30]. A Gi-isoform-specific regulation
of Akt could explain the calcium current increase in the case of
Gai3
2/2 and decrease in case of Gai2
2/2. To examine the
functional significance of Gai-dependent activation of Akt in vivo,
animals were treated with either saline or the muscarinic receptor
agonist carbachol (CCh, 0.5 mg/kg body weight) by i.p. injection;
15 min later animals were killed, and signalling activity was
assessed in heart preparations. Phosphorylation of Akt and its
downstream effector glycogen synthase kinase-3a/b (GSK3a/b),
were increased in cardiac tissue from all mouse strains after
treatment with CCh (Fig. 6A). Although the basal phosphorylation
of Akt in Gai2
2/2 and Gai3
2/2 cardiac tissue was slightly
increased compared to WT (to 138644% and 143658% of WT,
respectively), we could not observe statistically significant differ-
ences between CCh stimulated WT (233614% to basal), Gai2
2/2
(201627%) and Gai3
2/2 (195625%) mice (each n=3). Impor-
tantly, the total amount of Akt was not changed in all mice models.
Thus, Gi-subtype specific channel regulation seems to be
independent of Akt phosphorylation in the investigated knockout
models.
Lack of Gai2 protein abolishes ERK1/2 activation
Recently, a marked increase of L-type calcium channel density
that involved PKC-dependent activation of the ERK1/2 pathway
was reported [31]. To determine its involvement, we measured the
Table 2. Single-channel gating in WT and Gai3
2/2 myocytes.
Parameter WT Gai3
2/2
i [pA] 20.8160.02 20.8060.03
Ipeak [fA] 248613 261612
factive (%) 76648 3 67
Popen (%) 4.261.1 5.461.0
topen [ms] 0.4860.06 0.2960.02*
topen [ms] 0.4260.05 0.2660.03*
tclosed [ms] 6.560.9 3.860.5*
tclosed,1 [ms] 0.3460.02 0.3660.04
tclosed,2 [ms] 15.561.5 10.261.7*
proportion (tclosed,1:tclosed,2) 2.060.4 2.260.3
fl [ms] 27.164.1 18.662.4
Analysis of single-channel gating parameters in ventricular myocytes from WT
(n=7) and Gai3
2/2 (n=6) mice. Recordings with more than one channel were
excluded from the analysis. i: unitary current; Ipeak: peak ensemble average
current; factive: fraction of traces showing at least one opening; Popen: open
probability in active traces; topen: mean duration of openings; topen: dwell time
constant of the open state; tclosed: mean duration between two consecutive
openings; tclosed,1: dwell time constant of the fast closed time component;
tclosed,2: dwell time constant of the slow closed time component; proportion:
ratio of events conferring to either the fast or the slow closed time component;
fl: mean latency until the first opening.
*: p,0.05 vs. WT.
doi:10.1371/journal.pone.0024979.t002
Figure 3. RNA expression levels of cardiac Gai/o isoforms measured by real-time PCR. GAPDH was used as endogenous control, and WT
mice as calibrator (expression=100%; n=4). (A) 2
2DCT values were calculated to analyze the relative expression of Gai/o isoforms in WT
cardiomyocytes. (B) The relative mean expression (2
2DDCT) reveals a significantly increased Gai3 mRNA content in ventricular tissue of Gai2
2/2 mice
(n=3) and significantly increased Gai2 mRNA levels in Gai3
2/2 mice (n=4). (C) Representative example of Gai2 and Gai3 protein expression in murine
ventricular tissue from WT, Gai2
2/2 and Gai3
2/2 mice. Cell membranes were isolated and Gai proteins were analyzed by immunoblotting using an
anti-Gacommon antibody. Shorter exposure times were used to analyse Gai2 protein. (D) Summarized protein expression data show an upregulation of
Gai3 in Gai2
2/2 mice and an upregulation of Gai2 in Gai3
2/2 mice (n=8). *p,0.05 vs. WT.
doi:10.1371/journal.pone.0024979.g003
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current density. PTX treatment by itself did not affect calcium current density. (B) Effects of PTX on steady-state inactivation, as gauged by the
midpoint voltage V0.5 of a Boltzmann function. No change is seen after 3 hours of drug-free incubation compared to 0 hour. PTX leads to a significant
leftward shift of V0.5 in WT (from 219.260.7 mV to 221.060.7 mV, n=7–18) and Gai3
2/2 (from 218.260.7 mV to 222.761.1 mV, n=11–13). (C) PTX
affects the recovery of the L-VDCC from inactivation. PTX inhibits the channel recovery in Gai3
2/2 (t from 189612 ms to 350626 ms, n=5–11).
*p,0.05 vs. WT,
{p,0.05 vs. Gai3
2/2,
"p,0.05 vs. 3 h without PTX.
doi:10.1371/journal.pone.0024979.g004
Gai Isoform-Specific Regulation of Ca
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2/2
mice demonstrated a significantly blunted increase of ERK1/2
phosphorylation in CCh-stimulated animals (12865% to basal,
n=3) compared to WT (26866%, n=3) and Gai3
2/2
(192620%, n=3) cardiomyocytes. Of note, in Gai2
2/2 and
Gai3
2/2 cardiac tissues, the basal ERK1/2 phosphorylation levels
were increased compared to WT basal phosphorylation (Fig. 6B),
while the total amount of ERK1/2 in the heart was the same in all
mouse models tested. These results indicate a Gai2-dependent
ERK1/2 phosphorylation and strongly suggest that ERK1/2 plays
an important role in isoform-specific Gai protein signalling.
Discussion
The two inhibitory G protein isoforms Gi2 and Gi3 are both
upregulated in heart failure [6,7,8]. One functionally important
target of Gi protein signalling is the L-VDCC, the crucial trigger of
cardiac excitation-contraction coupling. Gi-protein-mediated in-
hibition of L-VDCC has been demonstrated for b2-adrenergic [4]
and muscarinic [20] receptor signalling. In this context, we
previously provided single-channel evidence that Gai2 does not
confer the L-VDCC inhibition observed in mice with chronic
overexpression of the b2-adrenergic receptor [18]. On the other
hand, cardiac Gai2 (but not Gai3) seems necessary and sufficient to
mediate the muscarinic receptor-mediated L-VDCC inhibition
[20], presumably through the classical adenylyl cyclase pathway.
So far, no isoform-specific function could be assigned to cardiac
Gai3; however, Gi3 has been shown to be an exclusive and specific
regulator of autophagy in the liver [22,32].
The different behaviour of L-VDCC currents obtained with
isolated myocytes from Gai2
2/2 and Gai3
2/2 mice shown here
and previously [18] demonstrates contrasting functional roles of
these two Gai isoforms. Although the issue has also been addressed
by others [19,20,33], our study is the first to demonstrate small but
significant changes of basal whole-cell current density: a reduction
in myocytes from Gai2
2/2 mice and an increase in myocytes from
Gai3
2/2 mice. The altered steady-state inactivation and recovery
observed with Gai2
2/2 under basal conditions (Fig. 1C and D),
and with Gai3
2/2 myocytes after PTX treatment (Fig. 4B and C),
point to a modulation of gating properties specific to Gai2.I n
contrast to data presented here, Nagata et al. [20] did not detect a
significant difference in L-VDCC activity between myocytes from
WT, Gai2
2/2 and Gai3
2/2 mice. With respect to Gai2
2/2, this
finding can be explained by the different prepulse potentials: the
prepulse voltages (250 mV used by Nagata and co-workers vs.
240 mV in our case) - intended to inactivate primarily sodium
currents - lie within the descending part of steady-state inactivation
(Fig. 1C). This likely translates into the more reduced peak in the
Figure 5. Calcium channel subunit expression. (A) 2
2DCT values were calculated against GAPDH expression to analyze the relation of L-type
calcium channel subunits in WT cardiomyocytes (n=4). (B) No significant changes in the relative mean expression (2
2DDCT) were observed in
ventricular tissues from Gai2
2/2 (n=3) and Gai3
2/2 mice (n=4). (C) Representative example of Cava1 protein expression in murine ventricular tissue
from WT, Gai2
2/2 and Gai3
2/2 mice. (D) Quantification of Cava1 protein levels show no change in ventricles from Gai3
2/2,G ai2
2/2 and WT mice
(n=3).
doi:10.1371/journal.pone.0024979.g005
Gai Isoform-Specific Regulation of Ca
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compared Gai2
2/2 mice with Gai1
2/2/Gai3
2/2 double knockout
mice and found distinct effects on surface ECGs: in Gai2
2/2
animals (but not in the double knockout mice), the effective
refractory period was reduced and ventricular arrhythmias were
induced more easily. In summary, Gai2 protein deletion showed
dramatic consequences on channel regulation in vivo and ex vivo.
There are no changes of cardiac L-VDCC composition
regarding the main cardiac L-VDCC subunits, Cava1 and Cavb2
(Fig. 5B and D) that would explain the obtained effects on current
density. Furthermore, because of the compensatory upregulation
of the remaining Gai isoform in case of either Gai2 or Gai3
deficiency (Fig. 3B and D), it is difficult to attribute the observed
changes in L-VDCC regulation/function to the higher expression
of one Gai isoform or to the loss of the other or to both. Therefore,
given the novel functional effects reported here for cardiac Gai2
and Gai3, we have to consider a number of molecular pathways.
For instance, activation of Stim1 [34] may lead to altered L-
VDCC function and subcellular distribution. Enhanced endocy-
tosis and degradation of calcium channels can also be mediated by
activation of PIKfyve [35] and subsequent Cava1 targeting to
lysosomes. Further, the RGK proteins Rad and Rem expressed in
the heart [36] are appealing candidates, because they negatively
regulate both membrane expression and gating of L-VDCC
[37,38] while little is known about how these small GTP-binding
proteins are regulated themselves [39]. In our present study, we
focused on two other important molecular pathways since they are
significantly regulated by Gi-signalling. First, PI3-kinase Akt/PKB
signalling is known to be activated by cardiac Gai [29], and
Catalucci et al. [30] revealed a mechanism through which the PI3-
kinase Akt/PKB pathway modulates Ca
2+ entry in cardiac cells via
L-VDCC. Our data showed a CCh-induced Akt phosphorylation
independent of the deletion of either Gai isoform (Fig. 6A).
Second, it was demonstrated that deactivation of Gi leads to a
significant reduction in ERK1/2 phosphorylation and that this
effect was Gs- and Gq- independent [29,40]. In the present study,
we have shown that Gai2 deletion prevents phosphorylation of
ERK1/2. Recently, Smani et al. [31] found a leftward shift and a
marked increase in L-VDCC density induced by urocortin, which
involved PKC-dependent activation of the MAPK-ERK1/2
pathway. Based on these findings we propose that loss of activation
of L-VDCC by ERK1/2 might be a mechanism involved in
functional regulation of calcium current in Gai2 deficient mice.
A change of Gas mediated signalling might account for altered
calcium currents when a Gai is lacking. With this caveat in mind,
we demonstrated in our previous study that Gas protein expression
remained unaffected in hearts from mice deficient in the major
isoform Gai2 [18]. Yet, possible changes in associated proteins like
Gbc subunits might indirectly affect Ga mediated signalling [41].
Indeed, we observed that expression of Gb1/2 was slightly reduced
in Gai2
2/2, but not Gai3
2/2 (data not shown). In any case, our
single-channel analysis (in particular, the decrease in open time)
does not support the idea of enhanced Gas mediated, cAMP-
mediated signalling in Gai3-deficient hearts (Table 2).
The data presented here could not elucidate all effects seen in
the knockout animals. Thus, eventually, Gi3’s role in L-VDCC
regulation remains unclear, mainly in light of the absence of acute
PTX effects in Gai2
2/2 mice. However, due to the effects seen by
incubation without PTX, our findings suggest that the increment
in channel activity observed in the absence of Gai3 might be
driven by an in vivo mechanism, which is not preserved ex vivo
(Fig. 4A). It has also to be pointed out that the immunoblot data
reveal total cardiac membrane channel protein levels, which does
not necessarily match up the fraction of functional channels
located in the sacrolemma. Given our currently available methods
to analyze the subcellular localization of calcium channels and
their regulation, all of these ideas require further work, which for
technical reasons has to be done in recombinant systems.
Taken together, our data reported here and in a previous paper
[18] point to the (patho-) physiological importance of subtype-
specific Gi protein signalling in the heart. In particular, in terminal
heart failure, Gai2 upregulation now appears as an attractive
mechanism linked to remodelling of L-VDCC [13,14,15,16].
Therefore, the present study provides new insights into potential
mechanisms linking modulation of L-VDCC to the inhibitory G
protein isoform Gi2 in cardiomyocytes, and highlights Gi2-specific
signalling via ERK1/2. Further research needs to focus on
detailed signalling pathways involving ERK1/2.
Methods
Ethic statement
Animal breeding, maintenance and experiments were approved
by the responsible federal state authority (Landesamt fu ¨r Natur-,
Umwelt- und Verbraucherschutz Nordrhein-Westfalen; reference
No. K 27, 24/04 and 8.87-51.05.20.09.232) and the responsible
local authority (Umwelt- und Verbraucherschutzamt der Stadt
Ko ¨ln; reference No. 576/1.36.6.3.-47/08 Be). All animal exper-
iments conform with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996).
Animals
Generation, breeding and characterization of Gai2-o rG ai3-
deficient mice have been described previously [18,22,42,43,44,45].
All Gai-deficient mouse strains used were backcrossed onto a
C57Bl6 background for .10 generations. Knockout and WT
control mice were maintained at the animal facilities of the
Heinrich-Heine-University, Du ¨sseldorf, and of the Department of
Pharmacology at the University of Cologne. Mice analyzed in this
study were of both sexes, 3–9 months of age and weighted 20–
35 g.
Genotyping
Tail-clip analysis was performed on 3–4 weeks old mice.
Genomic DNA was prepared and genotyping PCR for Gai2 and
Gai3 was performed as described previously [18,43].
Real time PCR
Primer for Gai1,G ai2,G ai3 isoforms and Cava1 subunit were
described previously [25,46]. Specific primers for the Gao and
Cavb2 subunit were designed using Primer Express Software v3.0
Figure 6. Signalling events downstream of Gai stimulation. Representative western blot of cardiac tissues of animals treated either with saline
or CCh (0.5 mg/kg body weight) for 15 min. (A) Western Blot and densitometry analyses of ventricular homogenates show that Akt phosphorylation
was significantly and to a similar extent increased after CCh stimulation in all genotypes (n=3). Total amount of Akt protein was unaltered and was
used as loading control. (B) Western blot showing ERK1/2 phosphorylation and total ERK1/2 expression and bar graphs of combined results expressed
as increase in pERK1/2 normalized to total ERK1/2 and compared to saline treated WT mice. The increase of ERK1/2 activation in CCh treated cells was
markedly inhibited by Gai2 gene deletion compared to WT and Gai3
2/2 mice (n=3). *p,0.05 vs. WT NaCl.
doi:10.1371/journal.pone.0024979.g006
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ATCGTAGAAACCCACTT-39 (sense) and 59-CGACGTCAAA-
CAGCCTGAAG-39 (antisense) and for Cavb2:5 9-GGGAGG-
CAGTACGTAGAGAAGCT-39 (sense) and 59-TGCAAATG-
CAACAGGTTTT GTC-39 (antisense). Total cellular RNA
was extracted from murine heart (ventricle) according to the
manufacturer’s protocol (Qiagen QIAshredder and RNeasy Mini
Kit, Qiagen, Hilden, Germany). For qualitative analysis of RNA
integrity, 2 mg of total RNA was separated on a 1% formaldehyde
agarose gel. Total RNA was subsequently converted into cDNA by
ImProm-II Reverse Transcription Kit (Promega, Mannheim,
Germany). Real-time PCR was carried out using the 7500 Real-
Time PCR system (Applied Biosystems) under standard conditions
with 200 pM PCR primers. Each sample was analyzed in triplets
using SYBR green (Applied Biosystems) as fluorescent detector
and GAPDH as endogenous control.
Cell membrane preparation
Murine cardiac ventricles were disrupted and homogenised in a
lysis buffer containing 10 mM Tris-HCl (pH 7.4), 1 mM EDTA,
0.5 mM DTT, and an EDTA-free protease inhibitor cocktail
(Roche, Penzberg, Germany) using an ultra-turrax blender.
Cellular membranes were isolated by two steps of centrifugation
at 450 g and 30.000 g. Membrane pellets were subsequently
dissolved in a buffer consisting of a freezing supplement (70 mM
Tris (pH 7.4), 12 mM MgCl2, 60% Glycerol, 240 mg/ml DNAse)
and the lysis buffer in a ratio of 1:6 in order to stabilize membrane-
associated proteins.
Phosphorylation assay
Animals were injected i.p. with 0.5 mg/kg carbachol (CCh)
diluted in 0.9% normal saline. Sham injections were performed
with 400 ml 0.9% saline per 30 g weight. After 15 min ventricular
tissue was harvested and lysed in buffer (50 mM HEPES, 1%
Triton, 50 mM NaCl, 10 mM Na3VO4, 0.1% SDS, 0.1 M NaF,
10 mM EDTA, complete mini protease inhibitor, pH 7.4) and left
for 30 min at 4uC. Total cell lysates were extracted from the
supernatant by centrifugation at 13.500 g for 20 min.
Immunoblotting
Gai and Cava1 proteins isolated from cell membranes were
separated on 6 M urea/9% SDS-PAGE gels (protein content per
lane was 90 mg) and on 8% SDS-PAGE gels (protein content per
lane was 100 mg), respectively [22]. Protein kinase B/Akt and
ERK1/2 in total cell lysates were separated on 10% SDS-PAGE
gels (100 mg protein content per lane). Separated proteins were
blotted onto nitrocellulose membranes (Hybond C extra; Amer-
sham Bioscience). Gai proteins were detected with an anti-
Gacommon antibody [45] (1:1000) and Cava1 with an anti-Cava1
antibody (1:200; Sigma Aldrich). For detection of phosphorylation,
membranes were incubated with phospho-Akt (Ser473), phospho-
GSK3a/b (Ser21/9) and phospho-ERK1/2 (Thr202/Tyr204)
antibodies. Membranes were reprobed with Akt and ERK1/2
antibodies (each 1:1000; Cell Signalling) after stripping. Emitted
light of stained membranes were captured on films and developed
in different expositions. Protein densities were calculated using
Aida Image Analyzer (Raytest, Straubenhardt, Germany) soft-
ware. The Ras-GTP-activating protein (RasGAP; [47]) was used
as a loading control for Cava1. Equal loading on blotting
membrane for Gai proteins was controlled by a non-specific
protein staining using Ponceau S. Only blots with equal loading
were analyzed. To confirm Gai band specificity, we performed
ADP ribosylation of PTX-sensitive G proteins as described [23].
Cardiomyocyte isolation
Single ventricular myocytes were isolated from hearts of 3–9
months old mice by enzymatic dissociation using a method
described previously [48]. Only rod shaped cardiomyocytes were
used for the experiments. Cells were maintained at room
temperature and subjected to patch-clamp analysis. If indicated,
a fraction of isolated ventricular myocytes was incubated without
or with 1.5 mg/ml of PTX (Sigma Aldrich, St. Louis, USA) for
3 hours at 37uC [24].
Single-channel measurements
Single-channel patch clamp recordings were done in the cell-
attached configuration as reported [18]. The composition of bath
solution was (mM): K-glutamate 120, KCl 25, MgCl2 2, HEPES
10, EGTA 2, CaCl2 1, Na2-ATP 1, glucose 10 (pH 7.4 with
KOH). Patch pipettes (7–9 MV) contained (mM): BaCl2 70,
HEPES 10, sucrose 110 (pH 7.4 with TEA-OH). Barium currents
were recorded at room temperature using a holding potential of
2100 mV and depolarizing test pulses to +20 mV (duration
150 ms, frequency 1.66 Hz, 180 sweeps per experiment mini-
mum). Data were sampled at 10 kHz and filtered at 2 kHz using
an Axopatch 200A amplifier (Axon Instruments, Sunnyvale, CA,
U.S.A.). Only experiments with one single active channel in the
patch were analyzed (identified by the lack of stacked openings).
Whole-cell current measurements
Conventional whole-cell patch clamp recordings were per-
formed with cells maintained at room temperature in bath solution
containing (mM): NaCl 137, CsCl 5.4, CaCl2 2, MgCl2 1, glucose
10, HEPES 10 (pH 7.4 with NaOH). Pipette (2–3 MV) solution
was composed of (mM): CsCl 120, MgCl2 1, Mg-ATP 4, EGTA
10, HEPES 5 (pH 7.2 with CsOH). Giga-Ohm seals (resistance 2–
5G V) were formed by gentle suction. At the beginning of each
experiment, membrane capacitance was measured by means of
fast depolarizing ramp pulses from 280 to 285 mV over 25 ms.
Cells were depolarized from a holding potential of 280 mV to a
50 ms prepulse to 240 mV in order to inactivate sodium
channels. This was followed by test pulse voltages ranging from
240 to +50 mV in 10 mV steps (pulse duration 150 ms). For time-
dependent inactivation, the declining raw currents at 210, 0, +10,
+20 and +30 mV were fitted by a double-exponential function,
yielding fast and slow time constant. For investigation of gating
kinetics, standard two-pulse protocols were used: the voltage-
dependent inactivation was measured after a prepulse of variable
amplitude and 250 ms duration, followed by a test pulse of fixed
amplitude for 50 ms. The midpoint voltage V0.5 was determined
by fitting a Boltzmann function to the data. Recovery from
inactivation was determined by two 200 ms depolarizing voltage
pulses to 0 mV. The interpulse interval at a holding potential of
245 mV was increased from 50 to 375 ms in 25 ms steps.
Recovery was fitted by a mono-exponential function, yielding the
recovery time constant t.
Statistical analysis
Data are presented as means 6 SEM. Patch-clamp data were
analyzed using pClamp software (CLAMPEX 6 and FETCHAN,
Axon Instruments). Analysis of L-VDCC kinetics was performed as
described previously [49] using GraphPad Prism 4. A one-sample t-
test was used to analyze normalized data. Differences between
genotypes were analyzed by one-way ANOVA followed by
Dunnett’s or Tukey’s post test, and between treatments within
one given genotype by two-tailed Student’s t tests. For electrophys-
iological statistics, number of cardiomyocytes from a minimum of 3
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evaluated. P values,0.05 were considered statistically significant.
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